ATE382623T1 - Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln - Google Patents

Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln

Info

Publication number
ATE382623T1
ATE382623T1 AT05754708T AT05754708T ATE382623T1 AT E382623 T1 ATE382623 T1 AT E382623T1 AT 05754708 T AT05754708 T AT 05754708T AT 05754708 T AT05754708 T AT 05754708T AT E382623 T1 ATE382623 T1 AT E382623T1
Authority
AT
Austria
Prior art keywords
octahydropyrrolo
antiviral agents
pyrrole derivatives
pyrrole
derivatives
Prior art date
Application number
AT05754708T
Other languages
English (en)
Inventor
Eun Lee
Chris Melville
David Rotstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE382623T1 publication Critical patent/ATE382623T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05754708T 2004-06-09 2005-06-01 Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln ATE382623T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57875904P 2004-06-09 2004-06-09

Publications (1)

Publication Number Publication Date
ATE382623T1 true ATE382623T1 (de) 2008-01-15

Family

ID=35431500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05754708T ATE382623T1 (de) 2004-06-09 2005-06-01 Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln

Country Status (21)

Country Link
US (2) US7164019B2 (de)
EP (1) EP1761542B1 (de)
JP (1) JP2008501743A (de)
CN (1) CN101001860A (de)
AR (1) AR049209A1 (de)
AT (1) ATE382623T1 (de)
AU (1) AU2005251891A1 (de)
BR (1) BRPI0511982A (de)
CA (1) CA2569910A1 (de)
DE (1) DE602005004144T2 (de)
DK (1) DK1761542T3 (de)
ES (1) ES2297727T3 (de)
IL (1) IL179534A0 (de)
MX (1) MXPA06014404A (de)
NO (1) NO20070137L (de)
PL (1) PL1761542T3 (de)
PT (1) PT1761542E (de)
RU (1) RU2006146608A (de)
TW (1) TW200701981A (de)
WO (1) WO2005121145A2 (de)
ZA (1) ZA200609837B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1940781A1 (de) 2005-10-19 2008-07-09 F.Hoffmann-La Roche Ag Phenylacetamid-nnrt-inhibitoren
CA2641389A1 (en) * 2006-02-15 2007-08-23 F. Hoffmann-La Roche Ag Hetero-bycyclic antiviral compounds
EP1987035A1 (de) * 2006-02-15 2008-11-05 F.Hoffmann-La Roche Ag Heterocyclische antivirale verbindungen
EP2057125B1 (de) 2006-08-16 2011-03-30 F. Hoffmann-La Roche AG Nicht-nukleosidische reverse-transkriptase-hemmer
WO2008030853A2 (en) * 2006-09-06 2008-03-13 Incyte Corporation Combination therapy for human immunodeficiency virus infection
EP2066674B1 (de) * 2006-09-18 2010-06-30 F.Hoffmann-La Roche Ag Octahydropyrrolo[3,4-c]pyrrolderivate und ihre verwendung als antivirale mittel
TWI454262B (zh) * 2006-11-02 2014-10-01 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
MX2009005881A (es) 2006-12-13 2009-06-12 Hoffmann La Roche Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
US8464207B2 (en) * 2007-10-12 2013-06-11 Novell Intellectual Property Holdings, Inc. System and method for tracking software changes
GB0724251D0 (en) 2007-12-12 2008-02-06 Univ Edinburgh Therapeutic compounds and their use
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
KR101702159B1 (ko) 2009-09-16 2017-02-02 더 유니버시티 오브 에든버러 （４―페닐―피페리딘―1―일）―［５―（1ｈ―피라졸―４―일）―티오펜―３―일］―메탄온 화합물 및 그의 용도
ES2534516T3 (es) 2010-01-07 2015-04-23 E.I. Du Pont De Nemours And Company Compuestos heterocíclicos fungicidas
ES2543692T3 (es) 2010-04-29 2015-08-21 The University Of Edinburgh (8-aza-biciclo[3.2.1biciclo[oct-8-il)-[5-(1H-pirazol-4-il)-tiofeno-3-il]-metanonas 3,3-disustituidas como inhibidores de 11beta-HSD1
DE102010025663A1 (de) * 2010-06-30 2012-01-05 Karl-Heinz Glüsenkamp Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate
TWI633087B (zh) 2012-06-13 2018-08-21 赫孚孟拉羅股份公司 新穎二氮雜螺環烷及氮雜螺環烷
EP3590940B1 (de) 2012-09-25 2021-06-09 F. Hoffmann-La Roche AG Hexahydropyrrolo[3,4-c]pyrrol-derivate und verwandte verbindungen als autotaxin (atx) inhibitoren und als inhibitoren der lysophosphatinsäure (lpa) produktion zur behandlung von z.b. nierenerkrankungen
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
EP3461827B1 (de) 2013-09-26 2022-02-23 Cadent Therapeutics, Inc. Selektive negative octahydro-cyclopenta[c]pyrrol-modulatoren von nr2b
NO3074400T3 (de) 2013-11-26 2018-04-14
CN104744451A (zh) * 2013-12-30 2015-07-01 中国科学院上海药物研究所 一种1-(3-氨基丙基)取代环状胺类化合物、其制备方法、药物组合物及用途
MA39792B1 (fr) 2014-03-26 2019-12-31 Hoffmann La Roche Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa)
EP3122751B1 (de) 2014-03-26 2019-10-30 F.Hoffmann-La Roche Ag Kondensierte [1,4]diazepin-verbindungen als hemmer der produktion von autotaxin (atx) und lysophosphatidsäure (lpa)
JO3579B1 (ar) 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
MX387736B (es) 2015-09-04 2025-03-18 Hoffmann La Roche Derivados de fenoximetilo.
CN107635995B (zh) 2015-09-24 2022-08-19 豪夫迈·罗氏有限公司 作为atx抑制剂的二环化合物
PE20180451A1 (es) 2015-09-24 2018-03-05 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores de atx
KR20180054634A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물
MX2017015034A (es) 2015-09-24 2018-04-13 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
MX2019000536A (es) 2016-07-14 2019-04-01 Pfizer Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
MA49879A (fr) 2017-03-16 2020-06-24 Hoffmann La Roche Composés hétérocycliques utiles en tant qu'inhibiteurs doubles d'atx/ca
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
IL298324A (en) * 2020-06-10 2023-01-01 Aligos Therapeutics Inc Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
JP2023533662A (ja) * 2020-06-10 2023-08-04 シクソン エービー 関節リウマチの治療におけるラベキシモド
CN113845439B (zh) * 2021-10-11 2024-02-09 杭州师范大学 双苄酰胺类cxcr4拮抗剂及其制备和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3930266A1 (de) 1989-09-11 1991-03-14 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4338396A1 (de) 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
US5457121A (en) 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
ATE252100T1 (de) * 1995-02-27 2003-11-15 Hoffmann La Roche Dioxopyrrolo-pyrrolderivate
GB9519563D0 (en) 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
AU4053497A (en) 1996-08-13 1998-03-06 Merck & Co., Inc. Palladium catalyzed indolization
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
WO2000055143A1 (en) * 1999-03-17 2000-09-21 F. Hoffmann-La Roche Ag Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators
TR200103214T2 (tr) 1999-05-04 2002-03-21 Schering Corporation CCR5 antagonistleri olarak yararlì piperazin trevleri.
CZ301161B6 (cs) 1999-05-04 2009-11-18 Schering Corporation Piperidinopiperidylový derivát užitecný jako CCR5 antagonista, farmaceutický prostredek jej obsahující
PT1236726E (pt) 1999-12-03 2005-04-29 Ono Pharmaceutical Co Derivados de triazaespiro[5.5]undecano e farmacos que os contem como ingrediente activo
WO2001044243A2 (en) 1999-12-14 2001-06-21 Neurosearch A/S Novel heteroaryl-diazabicycloalkanes
DE60023100T2 (de) 2000-01-05 2006-07-06 Pfizer Inc. Benzimidazol-Verbindungen zur Verwendung als ORL1-Rezeptor-Antagonisten
HRP20020938B1 (en) 2000-05-26 2011-05-31 Pfizer Inc. Tropane derivatives useful in therapy
US7381438B2 (en) 2000-07-21 2008-06-03 Ak Tood Technology, Inc. Liquid infusion and tenderization process, apparatus, and product
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
MXPA03008109A (es) * 2001-03-07 2003-12-12 Pfizer Prod Inc Moduladores de la actividad de receptores de quimiocinas.
GB0211418D0 (en) * 2002-05-17 2002-06-26 Glaxo Group Ltd Compounds
AR042628A1 (es) 2002-12-20 2005-06-29 Astrazeneca Ab Derivados de piperidina como moduladores del receptor ccr5

Also Published As

Publication number Publication date
PL1761542T3 (pl) 2008-06-30
ES2297727T3 (es) 2008-05-01
US7164019B2 (en) 2007-01-16
WO2005121145A3 (en) 2006-03-02
US7714018B2 (en) 2010-05-11
MXPA06014404A (es) 2007-02-19
US20070117859A1 (en) 2007-05-24
CN101001860A (zh) 2007-07-18
EP1761542A2 (de) 2007-03-14
RU2006146608A (ru) 2008-07-20
DE602005004144T2 (de) 2009-01-29
WO2005121145A2 (en) 2005-12-22
CA2569910A1 (en) 2005-12-22
TW200701981A (en) 2007-01-16
IL179534A0 (en) 2007-05-15
DE602005004144D1 (de) 2008-02-14
US20060014767A1 (en) 2006-01-19
PT1761542E (pt) 2008-03-26
ZA200609837B (en) 2008-09-25
EP1761542B1 (de) 2008-01-02
BRPI0511982A (pt) 2008-01-22
AR049209A1 (es) 2006-07-05
JP2008501743A (ja) 2008-01-24
AU2005251891A1 (en) 2005-12-22
DK1761542T3 (da) 2008-04-28
NO20070137L (no) 2007-03-06

Similar Documents

Publication Publication Date Title
DK1761542T3 (da) Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidler
ATE384725T1 (de) Pyrimido 4,5-d pyrimidinderivate mitantikrebswirkung
ATE395339T1 (de) Biphenylderivate und deren verwendung als fungizide
DE502005007196D1 (de) 8-ä3-amino-piperidin-1-ylü-xanthine, deren herstellung und deren verwendung als dpp-iv hemmer
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
DE60335151D1 (de) Pyrimidinderivate und deren Verwendung als CB2-Modulatoren
ATE466012T1 (de) Pyrazolo 3,4-b pyridinverbindungen und ihre verwendung als phosphodiesterase inhibitoren
ATE260917T1 (de) N-(5,7-dimethoxy(1,2,4)triazolo(1,5-a)pyrimidin 2-yl)arylsulfonamid verbindungen und deren verwendung als herbizide
DE602004027354D1 (de) SUBSTITUIERTE 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON- UND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATE UND DEREN VERWENDUNG BEI NEURODEGENERATIVEN KRANKHEITEN
ATE459605T1 (de) Isoxazolinderivate und deren verwendung als herbizide
ATE360632T1 (de) Substituierte 8&#39;-pyri(mi)dinyl-dihydrospiro- (cycloalkylamin)-pyrimido(1,2a)pyrimidin-6- onderivate
DE602005013491D1 (de) Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
ATE471938T1 (de) Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten
DE502005006424D1 (de) Neue alkyl-haltige 5-acylindolinone, deren herstellung und deren verwendung als arzneimittel
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
ATE487707T1 (de) (6-flu0r-benz0äl, 3üdioxolyl)-morpholin-4-yl- methanone und deren verwendung als cbl-liganden
ATE551329T1 (de) Chinazolinonderivate und deren verwendung als cb- agonisten
ATE472549T1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel
ATE417045T1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
UY29439A1 (es) Nuevos compuestos
ATE343582T1 (de) Derivate von (6, 7-dihydro -5h-imidazo(1,2 - a)imidazol -3 -sulfonylamino)-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen
DE602005022060D1 (de) Diaminoalkohole und deren verwendung als renininhibitoren
NL1030503A1 (nl) Octahydropyrrolo[3,4-c]-pyrroolderivaten.
ATE555097T1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
DE50313185D1 (de) 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1761542

Country of ref document: EP

REN Ceased due to non-payment of the annual fee